Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults.
Laurent C, Ngom Gueye NF, Ndour CT, Gueye PM, Diouf M, Diakhaté N, Touré Kane NC, Lanièce I, Ndir A, Vergne L, Ndoye I, Mboup S, Sow PS, Delaporte E; ANRS 1215/1290 Study Group.
Laurent C, et al.
J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):14-7. doi: 10.1097/00126334-200501010-00003.
J Acquir Immune Defic Syndr. 2005.
PMID: 15608518